University of Illinois at Urbana-Champaign

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Illinois at Urbana-Champaign sits in the top decile of US sponsors by registered trial count (#211 of 15,742 sponsors by registered trial count).

129 total trials 18 currently recruiting 101 completed early-phase tilt top decile by trial count

University of Illinois at Urbana-Champaign: 129 sponsored US clinical trials, 18 recruiting.

University of Illinois at Urbana-Champaign sponsors 129 registered US clinical trials on ClinicalTrials.gov, 18 of them currently recruiting, and 101 completed. 2 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 5 trials.

Top-decile sponsor footprint

University of Illinois at Urbana-Champaign ranks in the top decile of sponsors by registered trial count (#211 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

B 80/100

101 of 105 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (96.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

129 total, page 2 of 3

COMPLETED NA

Moderate-intensity Flow-based Yoga Effects on Cognition and Stress

NCT04740229

COMPLETED NA

Feasibility of Therapy Integrating Peer-sharing, Technology, Aerobic and Resistance Training (TIPSTART)

NCT04813198

COMPLETED NA

Yoga, Aerobic and Stretching Exercise Effects on Neurocognition

NCT04323163

COMPLETED NA

Illinois United ePREP Program Evaluation

NCT04378309

COMPLETED NA

The Effects of Mixed Working Memory Training on Subsequent Training Gains Among Older Adults

NCT05672771

COMPLETED NA

Effects of Almond Consumption on the Human Gastrointestinal Microbiota and Metabolic Health

NCT04223323

COMPLETED NA

Yoga and Aerobic Exercise Effects on Cognition

NCT04077645

COMPLETED NA

Time for Lunch: The Impact of Lunch Time Constraints on Child Eating Behaviors

NCT04191291

COMPLETED NA

Skeletal Muscle Protein Synthetic Response to Amino Acid and Peptides

NCT03952884

COMPLETED NA

A Video Chat Intervention for Enhancing Self-efficacy for Lifestyle Physical Activity

NCT03906955

COMPLETED NA

Individualized Diet Improvement Program for Weight Loss and Maintenance, Cohort 2

NCT04605640

COMPLETED NA

Food First Approach to Stimulate Muscle Protein Synthesis in Healthy Adults

NCT03870165

COMPLETED NA

Responsiveness to Acute Changes in Exercise and Relaxation (RACER) Trial

NCT03702712

COMPLETED NA

Aerobic Exercise and Cognitive Training Effects on Postconcussive Symptomology

NCT03674398

COMPLETED NA

Effects of Yoga, Strength Training and Aerobic Exercise on Cognition in Adult Cancer Survivors

NCT03650322

COMPLETED NA

Effect of Emotion Mindsets on Emotion Processing

NCT03978871

COMPLETED NA

Skeletal Muscle Protein Synthesis: Traditional and Cluster Sets

NCT04028726

COMPLETED NA

Health and Wellness in Healthcare Providers Post-disaster

NCT03722368

COMPLETED NA

Market to MyPlate: Investigating the Impact of a Nutrition and Hands-On Cooking Intervention

NCT04240782

COMPLETED NA

Effects of Prebiotics on Cognition and Health

NCT04551937

COMPLETED NA

Individualized Diet Improvement Program for Weight Loss and Maintenance, Cohort 1

NCT04605653

COMPLETED NA

Understanding Alcohol Reward in Social Context

NCT03449095

COMPLETED NA

Potato Ingestion and Time-trial Performance

NCT03294642

COMPLETED NA

Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms

NCT03011801

COMPLETED NA

Examining the Relationship Between Acute Meal Intake and Inflammation in Children

NCT03597542

COMPLETED Phase 2

Prostate Cancer Survivors and Exercise and Behavioral Counseling

NCT03191968

COMPLETED NA

The Influence of Regular Beef Consumption and Protein Density of the Diet on Training-induced Gains in Muscle Strength and Performance in Healthy Adults

NCT03029975

COMPLETED

Muscle Protein Synthesis in Dialysis Patients

NCT03478722

COMPLETED NA

Community Wise: An Innovative Multi-level Intervention to Reduce Alcohol and Illegal Drug Use

NCT02951455

COMPLETED NA

Cognitive Regulation Training and Exercise Trial

NCT03124667

COMPLETED NA

Resistance Exercise and Muscle Protein Synthesis in Obese Adults

NCT03411681

COMPLETED NA

Cognitive Distraction on Food Intake: Randomized Crossover Exploratory Study

NCT04078607

COMPLETED NA

Nutritional Strategies to Augment the Postprandial Muscle Protein Synthetic Response to the Ingestion of a Low Dose of Protein in Middle-aged Women

NCT02918981

COMPLETED NA

Effects of Probiotics on Cognition and Health

NCT02849275

COMPLETED Early Phase 1

Gut Microbiome Mediated Effects of Inulin Supplementation on Mineral and Bone Metabolism in Hemodialysis Patients

NCT02718885

TERMINATED

Alcohol and Bariatric Surgery

NCT02766322

COMPLETED NA

Acute Effects of Intradialytic Exercise on Cardiovascular Function in Hemodialysis Patients

NCT02753868

COMPLETED

Meta-analysis of Soluble Fiber Consumption on Body Weight, Glycemia, and Insulinemia in Overweight and Obese Adults.

NCT03003897

COMPLETED NA

Optimizing Cardiovascular Health and Physical Function in Hemodialysis Patients Through Volume Control and Exercise

NCT02627066

COMPLETED NA

Multiphase Activity Promotion Study

NCT02592590

COMPLETED NA

Heat & Aerobic Training (HEAT) Study

NCT02546726

COMPLETED NA

Activity & Cognition After Treatment for Breast Cancer

NCT02592070

COMPLETED NA

Muscle Protein Synthesis After Whole Egg vs. Egg White Consumption

NCT03117127

COMPLETED

Relationships Among Cognitive Function, Lifestyle, and Exercise After Cancer Treatment

NCT02523677

COMPLETED NA

Peer Education About Weight Steadiness

NCT02365324

COMPLETED NA

Metabolic Effects of Non-nutritive Sweeteners

NCT02413424

COMPLETED NA

Computerized Cognition Testing and Cognitive Motor Interference in MS

NCT02318576

COMPLETED NA

Acute Effects of Nutrition Supplementation on Treatment Efficiency and Hemodynamics During Dialysis

NCT02371018

COMPLETED NA

Time Course of Postprandial Protein Metabolism

NCT04121689

COMPLETED NA

Cognitive Motor Interference Rehabilitation in Persons With Multiple Sclerosis

NCT02274935

← Previous Page 2 of 3 Next →

Phase Distribution

PhaseTrial count
Phase 1 5
Phase 2 3
Phase 3 1
Phase 4 1

What is open in the University of Illinois at Urbana-Champaign pipeline

18 recruiting of 129 indexed (14% open); 101 completed (78%).

Phase mix: 2 late (III/IV) vs 8 early (I/II) (early-phase heavy).

Top condition: Multiple Sclerosis (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Illinois at Urbana-Champaign: open-pipeline peers nationwide

Peers matched on 129 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

University of Illinois at Urbana-Champaign sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20%25% Total trials Recruiting share University of Illinois at Urbana-ChampaignRhode Island HospitalJazz PharmaceuticalsNational Institute on Aging (NIA)Stony Brook UniversitySeattle Institute for Biomedical and Clinical ResearchUniversity of PennsylvaniaJohns Hopkins Bloomberg School of Public HealthMilton S. Hershey Medical Center
University of Illinois at Urbana-Champaign sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Illinois at Urbana-Champaign sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 129 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this University of Illinois at Urbana-Champaign page

129 registered trials is a research-attention snapshot, not an endorsement of University of Illinois at Urbana-Champaign or any single study.

  • 18 of University of Illinois at Urbana-Champaign's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Multiple Sclerosis is the condition University of Illinois at Urbana-Champaign studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Illinois at Urbana-Champaign pipeline card: 129 registered trials from official public datasets.Report a data error.